Multi-Omics Core
Multi-Omics Core
批准号:
10707437
负责人:
William Russell Renthal
金额:
$68.53万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-19 至 2027-08-31
关键词:
BackBenchmarkingBiological AssayCell CommunicationCell NucleusCellsChromiumConsultationsCore FacilityDNADataDevelopmentDissociationDropsEcosystemEmergency SituationEnsureFreezingFresh TissueGene ExpressionGenomicsGenotypeHigh-Throughput Nucleotide SequencingHourHumanIndividualInfrastructureLaboratoriesLearningLibrariesOutputPainPain ClinicsProcessProtocols documentationQuality ControlRNARecommendationReportingResearchResearch PersonnelResourcesSamplingSensory GangliaServicesTechnologyTimeTissuesTrainingXCL1 geneassay developmentcell typechronic paincostcost effectivecost effectivenessdata standardsepigenomicsexperiencehuman tissueimprovedinnovationmembermulti-ethnicmultidisciplinarymultiple omicsnext generation sequencingpain processingsingle cell analysistooltranscriptomicswhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (Multi-omics Core)
Single-cell transcriptomics is a central component of the PRECISION Human Pain Network because these
powerful new tools provide unprecedented opportunities for understanding the cell types, molecules, and cell-
cell interactions that contribute to chronic pain. The Multi-omics Core will be led by Dr. Renthal and centralizes
the single-cell transcriptomic, epigenomic, and next-generation sequencing efforts with an experienced team in
both the development, optimization, and analysis of single-cell and next-generation sequencing efforts. The
centralization of these cutting-edge technologies will ensure that the established protocols can be applied
systematically to all samples from the Center. Specifically, the Core will provide single-cell and single-nucleus
multi-omic services to characterize pain-related tissues in both Projects 1 and 2. They will then provide both
Projects rapid next-generation sequencing services with 1-3 day turnaround times at cost. Finally, the Core will
remain at the cutting-edge of the rapidly evolving field of single-cell genomics and continue to bring innovations
that improve quality and reduce costs back to the Center. The Core will also coordinate with similar Cores across
the U19 PRECISION Human Pain Network to reconcile protocols and best practices.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Next generation gene therapy for refractory pain
-
批准号:10366881
-
项目类别:
-
资助金额:$71.19万
-
财政年份:2022
-
负责人:William Russell Renthal
-
依托单位:
Administrative Core
-
批准号:10594335
-
项目类别:
-
资助金额:$20.11万
-
财政年份:2022
-
负责人:William Russell Renthal
-
依托单位:
Next Generation Gene Therapy for Refractory Pain
-
批准号:10553126
-
项目类别:
-
资助金额:$71.15万
-
财政年份:2022
-
负责人:William Russell Renthal
-
依托单位:
Project 1: Multi-omic characterization of human nociceptors
-
批准号:10594336
-
项目类别:
-
资助金额:$42.39万
-
财政年份:2022
-
负责人:William Russell Renthal
-
依托单位:
Administrative Core
-
批准号:10707423
-
项目类别:
-
资助金额:$18.12万
-
财政年份:2022
-
负责人:William Russell Renthal
-
依托单位:
Harvard PRECISION Human Pain Center
-
批准号:10594334
-
项目类别:
-
资助金额:$264.74万
-
财政年份:2022
-
负责人:William Russell Renthal
-
依托单位:
Harvard PRECISION Human Pain Center
-
批准号:10707416
-
项目类别:
-
资助金额:$257.86万
-
财政年份:2022
-
负责人:William Russell Renthal
-
依托单位:
Project 1: Multi-omic characterization of human nociceptors
-
批准号:10707426
-
项目类别:
-
资助金额:$40.19万
-
财政年份:2022
-
负责人:William Russell Renthal
-
依托单位:
Multi-Omics Core
-
批准号:10594340
-
项目类别:
-
资助金额:$81.06万
-
财政年份:2022
-
负责人:William Russell Renthal
-
依托单位:
Epigenomic labeling of cells that drive drug abuse behavior
-
批准号:10653905
-
项目类别:
-
资助金额:$53.7万
-
财政年份:2021
-
负责人:William Russell Renthal
-
依托单位:
Epigenomic labeling of cells that drive drug abuse behavior
-
批准号:10463789
-
项目类别:
-
资助金额:$53.7万
-
财政年份:2021
-
负责人:William Russell Renthal
-
依托单位:
Epigenomic labeling of cells that drive drug abuse behavior
-
批准号:10293229
-
项目类别:
-
资助金额:$53.7万
-
财政年份:2021
-
负责人:William Russell Renthal
-
依托单位:
CONTROL OF LONG GENE EXPRESSION AS A NOVEL THERAPEUTIC APPROACH FOR RETT SYNDROME
-
批准号:10189713
-
项目类别:
-
资助金额:$19.76万
-
财政年份:2019
-
负责人:William Russell Renthal
-
依托单位:
CONTROL OF LONG GENE EXPRESSION AS A NOVEL THERAPEUTIC APPROACH FOR RETT SYNDROME
-
批准号:10070245
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2019
-
负责人:William Russell Renthal
-
依托单位:
Control of long gene expression as a novel therapeutic approach for Rett syndrome
-
批准号:9294681
-
项目类别:
-
资助金额:$18.08万
-
财政年份:2017
-
负责人:William Russell Renthal
-
依托单位:
国内基金
海外基金
企业绩效评价的DEA-Benchmarking方法及动态博弈研究
-
批准号:70571028
-
项目类别:面上项目
-
资助金额:16.5万元
-
批准年份:2005
-
负责人:杨印生
-
依托单位: